12 Result: Israel
President Biden: America is a Beacon to the World
October 20th, 2023
President Joe Biden addressed the nation, highlighting the critical moment in history where the decisions made today will shape the future. He discussed his recent trip to Israel during a time of war, emphasizing the importance of preserving American. Read more
President Biden Takes Action as Hate Crimes Surge
October 17th, 2023
President Joe Biden addressed the latest FBI hate crime statistics. The data reveals a troubling surge in hate crimes, with a 25 percent increase in antisemitic hate crimes from 2021 to 2022. Antisemitism accounted for more than half of all reported . Read more
France, Germany, Italy, UK, and US Back Israel Amidst Hamas Attacks
October 10th, 2023
Leaders of France, Germany, Italy, the United Kingdom, and the United States have issued a joint statement reaffirming their unwavering support for Israel and condemning Hamas for its acts of terrorism. They stressed that there is never any justifica. Read more
President Biden Condemns Terrorist Attacks in Israel, Pledges Unwavering Support
October 07th, 2023
In response to the recent terrorist attacks in Israel orchestrated by Hamas, President Biden expressed his strong condemnation of the violence and assured unwavering support for Israel. He emphasized that the United States stands firmly with Israel i. Read more
Israeli Court's Determination Boosts Nano Dimension; Steelcase Outperforms Estimates
September 19th, 2023
Shares of Nano Dimension Ltd. (Nasdaq: NNDM) surged over 5% in after-hours trading following the company's announcement of receiving Israeli court approval to extend its share repurchase plan. The plan, originally approved by the Israeli court in Aug. Read more
Lockheed Martin Lands $2.77B+ Contract Modification; Domo Q2 Beats Street, Outlook Falls Short
August 24th, 2023
Sikorsky Aircraft Corp., a Lockheed Martin Corporation (NYSE: LMT) subsidiary, has secured a $2,774,583,756 fixed-price incentive (firm-target), firm-fixed-price modification to a previous contract. This modification encompasses Lots 7 and 8 block bu. Read more
Empowering Women and Countering Terrorism: Highlights of U.S.-Arab League Talks
July 20th, 2023
The United States and the Arab League successfully concluded talks in Washington, D.C., addressing critical issues including regional conflicts, climate change, women’s economic empowerment, and counterterrorism. The two parties reaffirmed thei. Read more
US Urges Israel to Fulfill Commitments Amid West Bank Settlements
June 19th, 2023
In a press statement issued by Matthew Miller, the Department Spokesperson, the United States expressed deep concern over the Israeli government's announcement to advance planning for over 4,000 settlement units in the West Bank. The reporte. Read more
SaverOne, NOVONIX, and Couchbase: Latest Updates and Trading Performance
June 07th, 2023
SaverOne 2014 Ltd. (Nasdaq: SVRE) announced an additional order from Universal Trucks Israel, Ltd. (UTI), which serves as the official Israeli importer for Isuzu vehicles, for the installation of SaverOne's In Cabin Driver Distraction Prevention Solu. Read more
Major Announcements in the Industry: Momentus Secures SpaceX Deal, Clearmind Medicine Receives Trial Approval, and SCYNEXIS Enters Exclusive License Agreement with GSK
May 12th, 2023
In recent updates, several companies have made significant announcements in their respective fields. Here's a breakdown of the latest developments: Momentus Inc. (Nasdaq: MNTS) has entered into a contract with SpaceX, securing a port reservation o. Read more
Lucintel Forecasts Magnesium Hydroxide Market to Reach $773 Million by 2025
April 10th, 2022
Dallas, TX / CRWE PRESS RELEASE / April 11, 2022 - According to the recent study the Magnesium hydroxide market is projected to reach an estimated $773 Million by 2025 from $618 Million in 2019, at a CAGR of 3.8% from 2020 to 2025. Growth in this mar. Read more
U.S. Food & Drug Administration Grants Orphan Drug Designation to Pluristem's PLX-PAD Cells for Treatment of Severe Preeclampsia
December 31st, 2015
HAIFA, ISRAEL / CRWEPRESSRELEASE / December 31, 2015 --Pluristem Therapeutics Inc. (NasdaqCM, TASE: PSTI), a leading developer of placenta-based cell therapy products, today announced that the U.S. Food and Drug Administration has granted the Co. Read more
Want To Find Some News?
News By Industries
Recent Post
-
Earnings Preview: Walt Disney, Applied Materials, and Celcuity Take Center Stage
November 11th, 2024Key Metrics: CyberArk Software, Hudbay Minerals, and Sonos Earnings Due
November 11th, 2024Earnings: What to Expect from Occidental Petroleum, Rocket Lab, and CAE
November 10th, 2024Earnings Countdown: Home Depot, Sea Limited, and Natera in the Spotlight
November 10th, 2024Ahead of Earnings: DoorDash, MetLife, and Exelon in the Spotlight
October 27th, 2024
Member Login